Heart failure with preserved and reduced ejection fraction: Different phenotypes in old-elderly patients?

被引:4
|
作者
Inmaculada Paez-Rubio, Maria [1 ]
Javier Carrasco-Sanchez, Francisco [1 ]
Escobar-Cervantes, Carlos [2 ]
Sanchez-Gomez, Nancy [3 ]
Luis Santiago-Ruiz, Jose [3 ]
Yebra-Yebra, Miguel [3 ]
Manzano, Luis [3 ]
机构
[1] Hosp Juan Ramon Jimenez, Dept Internal Med, Huelva, Spain
[2] Hosp La Paz, Dept Cardiol, Madrid, Spain
[3] Univ Alcala, Hosp Univ Ramon & Cajal, Dept Internal Med, Heart Failure & Vasc Risk Unit, Madrid, Spain
关键词
Heart failure; Preserved ejection fraction; Reduced ejection fraction; SYSTOLIC FUNCTION; DIAGNOSIS;
D O I
10.1016/j.ejim.2013.01.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with heart failure with preserved ejection fraction (HFPEF) represent an important group of patients presenting in clinical practice. However, whether it is an earlier stage of heart failure with reduced ejection fraction (HFREF) remains uncertain. We evaluated the potential progression of HFPEF to HFREF. Methods and results: We evaluated retrospectively 178 patients (mean age 80.5 +/- 5.8 years; 75.3% females) with heart failure with preserved ejection fraction from a specialized Internal Medicine unit, offering an integrated usual care. Diagnosis of heart failure with preserved ejection fraction was made according to European guidelines. The main objective was to evaluate the progression to systolic dysfunction, defined by left ventricular ejection fraction less than 45%. Mean baseline left ventricular ejection fraction was 64.6 +/- 7.2. After a mean follow-up of 24-months, mean baseline ejection fraction was 67.1 +/- 9.3%. Only five patients (2.8%) progressed to HFREF. Brain natriuretic peptide values were significantly higher in those patients who progressed. Conclusions: These results strongly suggest that heart failure with preserved and reduced ejection fraction could be distinct pathophysiological entities, at least in elderly patients. (C) 2013 European Federation of Internal Medicine. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:346 / 348
页数:3
相关论文
共 50 条
  • [21] Different impact and prevalence of hyperuricemia in patients with acute heart failure with preserved ejection fraction respect to reduced ejection fraction
    Palazzuoli, A.
    Ruocco, G.
    De Vivo, O.
    Nuti, R.
    Mccullough, P. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 41 - 42
  • [22] SERIAL CHANGE IN EJECTION FRACTION IN COMMUNITY HEART FAILURE PATIENTS WITH PRESERVED AND REDUCED EJECTION FRACTION
    Dunlay, Shannon
    Roger, Veronique L.
    Weston, Susan A.
    Redfield, Margaret M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E398 - E398
  • [23] QTc INTERVAL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION VS. HEART FAILURE WITH PRESERVED EJECTION FRACTION
    John, L. A.
    Christian, E. A.
    Harper, Y. I.
    Flatt, D. M.
    Heckle, M. R.
    Heard, B. Z.
    Jasper, J. B.
    Ramos, B. M.
    Weber, K. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 429 - 430
  • [24] Acute heart failure with preserved or reduced ejection fraction: is it bimodal or overlapping multiple phenotypes?
    Kashour, T.
    Alhabib, K.
    Alfaleh, H.
    Hersi, A.
    Thalib, L.
    Abuosa, A.
    Mimish, L.
    Alhabeeb, W.
    Almasood, A.
    Elasfar, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 505 - 506
  • [25] Risk factors for heart failure rehospitalization in patients with preserved ejection fraction : Comparison between preserved ejection fraction and reduced ejection fraction
    Setoguchi, M.
    Hashimoto, Y.
    Isobe, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S282 - S282
  • [26] Quality of Life in Elderly Patients with Heart Failure and Preserved Ejection Fraction
    Liu, Ming
    Yan, Bryan P.
    Lee, Alex Pui-Wai
    Lam, Yat-Yin
    Zhang, Qing
    Sanderson, John E.
    Sun, Jing-Ping
    Yu, Cheuk-Man
    CIRCULATION, 2012, 126 (21)
  • [27] Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Tromp, Jasper
    Khan, Mohsin A. F.
    Klip, IJsbrand T.
    Meyer, Sven
    de Boer, Rudolf A.
    Jaarsma, Tiny
    Hillege, Hans
    van Veldhuisen, Dirk J.
    van der Meer, Peter
    Voors, Adriaan A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):
  • [28] Utilization of spironolactone in patients with reduced or preserved ejection fraction heart failure
    Adimadhyam, Sruthi
    Cosgrove, Austin
    Her, Qoua L.
    Lyons, Jennifer
    Eworuke, Efe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 229 - 230
  • [29] Efficacy of Tolvaptan in Elderly Patients with Heart Failure and Preserved Ejection Fraction
    Suzuki, Yoriyasu
    Murata, Akira
    Tsujimoto, Satoshi
    Ochiumi, Yusuke
    Ito, Tatsuya
    JOURNAL OF CARDIOVASCULAR EMERGENCIES, 2019, 5 (02): : 59 - 65
  • [30] Lung ultrasound in patients with heart failure with reduced and preserved ejection fraction
    Gargani, L.
    Frassi, F.
    Piazzai, C.
    Marchiani, C.
    Bandini, G.
    Pignone, A. Moggi
    EUROPEAN HEART JOURNAL, 2018, 39 : 451 - 451